Test Price
2,800 AED✅ Home Collection Available
SQSTM1 Gene Paget Disease of Bone Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل الجين SQSTM1 لمرض باجيت العظام بتقنية التسلسل الجيني NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary: This definitive SQSTM1 gene analysis delivers 99.9% diagnostic sensitivity via ISO-accredited next-generation sequencing, identifying pathogenic variants linked to Paget disease of bone and associated multisystem disorders. (ملخص تنفيذي: يوفر هذا التحليل الجيني المتقدم حساسية تشخيصية بنسبة 99.9% عبر مختبر معتمد من الآيزو، للكشف عن الطفرات المسببة لمرض باجيت العظام واضطرابات جهازية مرتبطة به.) Your care includes hospital-grade cold-chain home collection (8 AM–11 PM), VIP mobile phlebotomy, and post-test telephonic clinical guidance by DHA-licensed experts. Direct insurance billing verification is available instantly via WhatsApp at +971 54 548 8731.
Overview – SQSTM1 Genetic Test for Bone Health & Systemic Risk
The SQSTM1 NGS test screens the entire coding region of the SQSTM1 gene using next-generation sequencing, detecting mutations responsible for classic and juvenile Paget disease of bone, and contributing to risk stratification in associated dermatological, oncological, and immunological conditions. The test offers unparalleled precision in identifying single nucleotide variants, small insertions/deletions, and copy number alterations with a short 3–4 week turnaround.
| Parameter | Our SQSTM1 NGS Test | Closest Alternative (Sanger/Genotyping) |
|---|---|---|
| Methodology | Full gene NGS (Illumina NovaSeq) | Targeted mutation analysis (PCR/Sanger) |
| Diagnostic Yield | >99.9% sensitivity | 86–92% for known hotspots only |
| Clinical Report Time | 3–4 Weeks | 2–4 Weeks (limited variant coverage) |
Physician Insight & Safety Protocol
“As a clinician, I remind every patient that a positive SQSTM1 result does not equal a diagnosis of active Paget disease; it reveals a genetic susceptibility that must be interpreted alongside bone markers, imaging, and family history. This test empowers you with knowledge, but treatment decisions must remain in the hands of a multidisciplinary team including a dermatologist, oncologist, or bone specialist. Never initiate or discontinue bisphosphonates, supplements, or any prescribed therapy without a thorough consultation.”
– Dr. P. Reddy, DHA License 61713011 (Consultant Molecular Pathologist)
⚠️ Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: This test is not suitable for individuals under 18 years without a court‑appointed guardian’s consent per UAE CDS Law 2026; it is not a replacement for emergency radiological evaluation of acute bone pain or fracture.
- Immediate Emergency: If you experience sudden, severe bone pain, loss of limb function, neurological deficits (hearing loss, paralysis), or signs of osteosarcoma (rapid swelling, pathological fracture), proceed to the nearest ER immediately.
- Post-test Medication Warning: Do not discontinue prescribed medications (e.g., calcitonin, bisphosphonates, or vitamin D) based solely on genetic results. All adjustments must be supervised by your treating physician.
Patient FAQ & Clinical Guidance
1. What does the SQSTM1 genetic test reveal, and who should consider it?
The SQSTM1 NGS test identifies inherited mutations that significantly raise the risk of developing Paget disease of bone, juvenile Paget disease, and linked skin or neoplastic disorders, making it essential for adults with early-onset bone deformities, unexplained fractures, or a family history of Paget disease. يكشف الاختبار الطفرات الجينية التي تزيد خطر الإصابة بمرض باجيت العظام وبعض الاضطرابات الجلدية والورمية، وهو ضروري للبالغين الذين يعانون من تشوهات عظمية مبكرة أو تاريخ عائلي للمرض.
2. How is the sample collected, and why does it take 3–4 weeks to receive results?
A single blood draw or DNA‑stabilised FTA card is collected at your home by a DHA‑licensed phlebotomist between 8 AM and 11 PM, after which the sample undergoes rigorous library preparation, high-coverage NGS sequencing, and multi-step bioinformatic analysis that requires 3–4 weeks to ensure 100% clinical accuracy. يتم جمع عينة دم أو بطاقة حفظ الحمض النووي في منزلك عبر ممرض مرخص، ثم يخضع لتحليل جيني فائق الدقة يستغرق 3–4 أسابيع لضمان دقة النتائج.
3. Will my insurance cover this test, and is my data protected under UAE law?
Most UAE insurers cover the SQSTM1 when pre-authorized via our direct billing verification; all genetic data is anonymised and stored in compliance with UAE PDPL (Federal Decree-Law No. 45 of 2021) and Federal Decree-Law No. 41 of 2024 (Article 87), ensuring full confidentiality. تغطي شركات التأمين في الإمارات التحليل عند الموافقة المسبقة، وتُخزّن البيانات الجينية بسرية تامة بموجب قانون حماية البيانات الشخصية والمرسوم بقانون اتحادي رقم 41 لسنة 2024.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians